Insider Trading Alert - OLN, BKU, ILMN, MOH And QCOM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 3, 2014, 88 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $108.30 to $608,047,660.00.

Highlighted Stocks Traded by Insiders:

Olin Corporation (OLN) - FREE Research Report

Greer GBruce who is VP,Strategic Plan.&Info. Tech. at Olin Corporation sold 1,918 shares at $25.53 on Feb. 3, 2014. Following this transaction, the VP,Strategic Plan.&Info. Tech. owned 4,252 shares meaning that the stake was reduced by 31.09% with the 1,918-share transaction.

The shares most recently traded at $25.11, down $0.42, or 1.67% since the insider transaction. Historical insider transactions for Olin Corporation go as follows:

  • 4-Week # shares bought: 12,500
  • 4-Week # shares sold: 6,120
  • 12-Week # shares bought: 12,500
  • 12-Week # shares sold: 10,620
  • 24-Week # shares bought: 12,500
  • 24-Week # shares sold: 10,620

The average volume for Olin Corporation has been 1.4 million shares per day over the past 30 days. Olin Corporation has a market cap of $2.0 billion and is part of the basic materials sector and chemicals industry. Shares are down 13.24% year-to-date as of the close of trading on Monday.

Olin Corporation manufactures and sells chlor alkali products in the United States and internationally. It operates in three segments, Chlor Alkali Products, Chemical Distribution, and Winchester. The stock currently has a dividend yield of 3.11%. The company has a P/E ratio of 11.6. Currently there is 1 analyst that rates Olin Corporation a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OLN - FREE

TheStreet Quant Ratings rates Olin Corporation as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, notable return on equity, increase in stock price during the past year and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Olin Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

BankUnited (BKU) - FREE Research Report

Ross Wilbur L Jr who is Director at BankUnited sold 2.1 million shares at $31.40 on Feb. 3, 2014. Following this transaction, the Director owned 3.4 million shares meaning that the stake was reduced by 38% with the 2.1 million-share transaction.

The shares most recently traded at $30.40, down $1.00, or 3.29% since the insider transaction.

The average volume for BankUnited has been 594,800 shares per day over the past 30 days. BankUnited has a market cap of $3.1 billion and is part of the financial sector and banking industry. Shares are down 7.49% year-to-date as of the close of trading on Monday.

BankUnited, Inc., a bank holding company, provides a range of banking products and financial services to commercial and middle-market businesses, and individual customers in the United States. The stock currently has a dividend yield of 2.7%. The company has a P/E ratio of 15.5. Currently there are 3 analysts that rate BankUnited a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BKU - FREE

TheStreet Quant Ratings rates BankUnited as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full BankUnited Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Illumina (ILMN) - FREE Research Report

Bianchi Paul L who is Sr VP, Human Resources at Illumina sold 663 shares at $151.53 on Feb. 3, 2014. Following this transaction, the Sr VP, Human Resources owned 60,374 shares meaning that the stake was reduced by 1.09% with the 663-share transaction.

The shares most recently traded at $151.16, down $0.37, or 0.24% since the insider transaction. Historical insider transactions for Illumina go as follows:

  • 4-Week # shares sold: 696
  • 12-Week # shares sold: 10,696
  • 24-Week # shares sold: 42,323

The average volume for Illumina has been 1.6 million shares per day over the past 30 days. Illumina has a market cap of $19.2 billion and is part of the health care sector and drugs industry. Shares are up 37.44% year-to-date as of the close of trading on Monday.

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company has a P/E ratio of 84.4. Currently there are 8 analysts that rate Illumina a buy, no analysts rate it a sell, and 10 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ILMN - FREE

TheStreet Quant Ratings rates Illumina as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Illumina Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Molina Healthcare (MOH) - FREE Research Report

White Joseph W Cpa who is VP, Accounting at Molina Healthcare sold 1,329 shares at $35.98 on Feb. 3, 2014. Following this transaction, the VP, Accounting owned 95,320 shares meaning that the stake was reduced by 1.38% with the 1,329-share transaction.

The shares most recently traded at $35.12, down $0.86, or 2.45% since the insider transaction. Historical insider transactions for Molina Healthcare go as follows:

  • 4-Week # shares sold: 2,374
  • 12-Week # shares sold: 2,374
  • 24-Week # shares sold: 150,891

The average volume for Molina Healthcare has been 533,600 shares per day over the past 30 days. Molina Healthcare has a market cap of $1.6 billion and is part of the health care sector and health services industry. Shares are up 1.96% year-to-date as of the close of trading on Monday.

Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, as well as to assist state agencies in their administration of the Medicaid program. The company has a P/E ratio of 21.8. Currently there are 3 analysts that rate Molina Healthcare a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOH - FREE

TheStreet Quant Ratings rates Molina Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Molina Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Qualcomm (QCOM) - FREE Research Report

Jacobs Paul E who is Chairman & CEO at Qualcomm sold 9,692 shares at $73.07 on Feb. 3, 2014. Following this transaction, the Chairman & CEO owned 418,058 shares meaning that the stake was reduced by 2.27% with the 9,692-share transaction.

The shares most recently traded at $72.80, down $0.27, or 0.37% since the insider transaction. Historical insider transactions for Qualcomm go as follows:

  • 4-Week # shares sold: 13,315
  • 12-Week # shares sold: 156,665
  • 24-Week # shares sold: 185,427

The average volume for Qualcomm has been 10.7 million shares per day over the past 30 days. Qualcomm has a market cap of $125.5 billion and is part of the technology sector and telecommunications industry. Shares are down 0.04% year-to-date as of the close of trading on Monday.

QUALCOMM Incorporated designs, develops, manufactures, and markets digital communications products and services based on code division multiple access (CDMA), orthogonal frequency division multiple access (OFDMA), and other technologies. The stock currently has a dividend yield of 1.89%. The company has a P/E ratio of 20.3. Currently there are 20 analysts that rate Qualcomm a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on QCOM - FREE

TheStreet Quant Ratings rates Qualcomm as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Qualcomm Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Trump, Trade Wars, General Electric, 'Jurassic World' - 5 Things You Must Know

Trump, Trade Wars, General Electric, 'Jurassic World' - 5 Things You Must Know

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

Boeing Slides as China Premier Li Says Willing to Continue Talks With Airbus

US Auto Tariffs Would Hit Global Industry Ratings; Ford & GM Vulnerable- Moody's

US Auto Tariffs Would Hit Global Industry Ratings; Ford & GM Vulnerable- Moody's

Futures Fall on Further Trade News and 4 Other Stories to Watch Monday Morning

Futures Fall on Further Trade News and 4 Other Stories to Watch Monday Morning

Stocks Weaken Around The World as Trump Opens New Fronts in Global Trade War

Stocks Weaken Around The World as Trump Opens New Fronts in Global Trade War